603301.SS SHH
Zhende Medical Co., Ltd.
1W: -6.0%
1M: -8.0%
3M: -10.6%
YTD: -15.3%
1Y: +238.3%
3Y: +187.6%
5Y: +99.1%
¥75.17 ($11.21)
-0.63 (-0.83%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$4.3B
+3.3% ▲
5Y CAGR: +18.0%
Gross Profit
$1.4B
+10.7% ▲
5Y CAGR: +19.0%
Operating Income
$492M
+117.7% ▲
5Y CAGR: +19.7%
Net Income
$385M
+94.1% ▲
5Y CAGR: +19.7%
EPS (Diluted)
$1.45
+95.9% ▲
5Y CAGR: +12.6%
EBITDA
$612M
+28.6% ▲
5Y CAGR: +21.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $10.4B | $5.1B | $6.1B | $4.1B | $4.3B |
| YoY Growth | +456.7% | -51.0% | +20.5% | -32.8% | +3.3% |
| Cost of Revenue | $5.6B | $3.4B | $4.1B | $2.9B | $2.9B |
| Gross Profit | $4.8B | $1.7B | $2.1B | $1.3B | $1.4B |
| Gross Margin | 46.5% | 34.1% | 33.8% | 30.9% | 33.2% |
| R&D Expenses | $260M | $153M | $227M | $139M | $135M |
| SG&A Expenses | $865M | $795M | $977M | $890M | $886M |
| Operating Expenses | $1.3B | $916M | $1.3B | $1.1B | $922M |
| Operating Income | $3.5B | $822M | $813M | $226M | $492M |
| Operating Margin | 34.0% | 16.1% | 13.2% | 5.5% | 11.5% |
| Interest Expense | $23M | $27M | $35M | $31M | $32M |
| Income Before Tax | $3.5B | $820M | $802M | $219M | $475M |
| Tax Expense | $561M | $99M | $100M | $5M | $78M |
| Net Income | $2.5B | $596M | $680M | $198M | $385M |
| Net Margin | 24.5% | 11.7% | 11.1% | 4.8% | 9.0% |
| EPS (Diluted) | $12.50 | $2.63 | $2.87 | $0.74 | $1.45 |
| EBITDA | $3.7B | $859M | $998M | $476M | $612M |
| Shares Outstanding | 204M | 227M | 237M | 268M | 266M |